...
首页> 外文期刊>Cellular Oncology: Analytical Cellular Pathology >miR-590-3p and Its Downstream Target Genes in HCC Cell Lines
【24h】

miR-590-3p and Its Downstream Target Genes in HCC Cell Lines

机译:HCC细胞系中的miR-590-3p及其下游靶基因

获取原文
   

获取外文期刊封面封底 >>

       

摘要

miRNAs are small non-coding RNA sequences of 18-25 nucleotides. They can regulate different cellular pathways by acting on tumor suppressors, oncogenes, or both. miRNAs are mostly tissue-specific, and their expression varies depending on the cancer or the tissue in which they are found. hsa-miR-590-3p was found to be involved in several types of cancers. In this study, we identified potential downstream target genes of hsa-miR-590-3p computationally. Several bioinformatics tools and more than one approach were used to identify potential downstream target genes of hsa-miR-590-3p. CX3CL1, SOX2, N-cadherin, E-cadherin, and FOXA2 were utilized as potential downstream target genes of hsa-miR-590-3p. SNU449 and HepG2, hepatocellular carcinoma cell lines, were used to carry out various molecular techniques to further validate our in silico results. mRNA and protein expression levels of these genes were detected using RT-PCR and western blotting, respectively. Co-localization of hsa-miR-590-3p and its candidate downstream target gene, SOX2, was carried out using a miRNA in situ hybridization combined with immunohistochemistry staining through anti-SOX2. The results show that there is an inverse correlation between hsa-miR-590-3p expression and SOX2 protein expression in SNU449. Subsequently, we suggest that SOX2 can be a direct downstream target of has-miR-590-3p indicating that it may have a role in the self-renewal and self-maintenance of cancer cells. We also suggest that CX3CL1, E-cadherin, N-cadherin, and FOXA2 show a lot of potential as downstream target genes of hsa-miR-590-3p signifying its role in epithelial-mesenchymal transition. Studying the expression of hsa-miR-590-3p downstream targets can enrich our understanding of the cancer pathogenesis and how it can be used as a therapeutic tool.
机译:miRNA是18-25个核苷酸的小非编码RNA序列。它们可以通过作用于肿瘤抑制剂,诱发剂或两者来调节不同的细胞途径。 MiRNA大多是组织特异性的,它们的表达根据癌症或组织而变化。发现HSA-MIR-590-3P参与了几种类型的癌症。在这项研究中,我们在计算上识别了HSA-MIR-590-3P的潜在下游靶基因。用于识别HSA-MIR-590-3P的潜在下游靶基因的几种生物信息工具和多种方法。 CX3Cl1,Sox2,N-Cadherin,E-Cadherin和FoxA2被用作HSA-miR-590-3p的潜在下游靶基因。 SNU449和HepG2,肝细胞癌细胞系用于进行各种分子技术,以进一步验证我们的硅效果。使用RT-PCR和Western印迹检测这些基因的mRNA和蛋白表达水平。使用MiRNA与免疫组织化学通过抗SOX2结合免疫组织化学染色,进行HSA-miR-590-3P及其候选下游靶基因SOX2的共定位。结果表明,在SNU449中HSA-miR-590-3P表达和SOX2蛋白表达之间存在反比相关性。随后,我们建议SOX2可以是具有MIR-590-3P的直接下游靶标,表明它可能在癌细胞的自我更新和自我维持中具有作用。我们还表明CX3Cl1,E-Cadherin,N-Cadherin和FoxA2表现出许多潜在的HSA-MIR-590-3P下游靶基因,其在上皮间充质转换中致力于其作用。研究HSA-MIR-590-3P下游靶标的表达可以丰富我们对癌症发病机制的理解以及如何用作治疗工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号